¿Es etelcalcetida más eficaz que maxacalcitol para disminuir la propensión a calcificaciones vasculares en el tratamiento del hiperparatiroidismo secundario?
Pedro Barrera Baenaa,c, Clara Sanz Garcíaa,c, Beatriz Martín Carrob,c, Julia Martín Vírgalab,c, Manuel Naves Díazb,c, Jorge B. Cannata Andíab,c,d
a Área de Gestión Clínica de Nefrología. Hospital Universitario Central de Asturias. Oviedo.
b Unidad de Gestión Clínica de Metabolismo Óseo. Hospital Universitario Central de Asturias. Oviedo.
c Metabolismo Óseo, Vascular y Enfermedades Inflamatorias Crónicas. Instituto de Investigación Sanitaria del Principado de Asturias. Oviedo.
d Departamento de Medicina. Universidad de Oviedo. Oviedo.
Read
1958
Timeswas read the article
1034
Total PDF
924
Total HTML
Article information
ISSN: 18889700Original language: Spanish
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 July | 21 | 26 | 47 |
| 2024 June | 38 | 54 | 92 |
| 2024 May | 55 | 38 | 93 |
| 2024 April | 37 | 26 | 63 |
| 2024 March | 46 | 37 | 83 |
| 2024 February | 46 | 32 | 78 |
| 2024 January | 40 | 34 | 74 |
| 2023 December | 21 | 31 | 52 |
| 2023 November | 25 | 32 | 57 |
| 2023 October | 45 | 36 | 81 |
| 2023 September | 66 | 39 | 105 |
| 2023 August | 58 | 27 | 85 |
| 2023 July | 38 | 33 | 71 |
| 2023 June | 30 | 38 | 68 |
| 2023 May | 40 | 33 | 73 |
| 2023 April | 28 | 24 | 52 |
| 2023 March | 28 | 41 | 69 |
| 2023 February | 34 | 22 | 56 |
| 2023 January | 32 | 37 | 69 |
| 2022 December | 25 | 33 | 58 |
| 2022 November | 39 | 51 | 90 |
| 2022 October | 30 | 116 | 146 |
| 2022 September | 39 | 49 | 88 |
| 2022 August | 37 | 84 | 121 |
| 2022 July | 26 | 61 | 87 |
Show all
